Background BMI is known to be strongly associated with all-cause mortality, but few studies have been large enough to reliably examine associations between BMI and a comprehensive range of cause-specific mortality outcomes.
Introduction
High BMI contributed to an estimated 4 million deaths globally in 2015. 1 Several major studies and meta-analyses have found strong associations between BMI and allcause mortality; most have described a U-shaped association with minimum mortality in the healthy weight (20) (21) (22) (23) (24) (25) kg/m²) range; 2-5 a 2013 meta-analysis suggested that overweight might be protective 6 but concerns were raised about whether the study had adequately accounted for age, reverse causality, and confounding by smoking. 7 A recent large meta-analysis, which explored the effect of different methodological decisions on results, observed a higher nadir of the BMImortality curve when studies with short follow-up (and thus increased susceptibility to reverse causality) were included, and when ever-smokers were included. 2 There is less evidence about the associations between BMI and cause-specific mortality outcomes. Among studies investigating cardiovascular mortality, increased BMI has generally been associated with increased risk, 4, 5, 8, 9 but it is unclear whether risk begins to increase with overweight 5 or only with obesity, 10 and whether underweight affects risk. 4, 9 U-shaped or J-shaped associations have been found between BMI and all-cancer mortality 4 but there is evidence of variation by cancer site based on studies looking at a range of site-specific cancers. 11 Drawing out patterns from existing evidence is complicated by variation in study settings and populations; in analytical strategy, including inclusion and exclusion of smokers, inclusion and exclusion of early follow-up time, and handling of pre-existing disease; and in the range and granularity of outcomes considered.
We aimed to examine in detail the association of BMI with all-cause and cause-specific mortality outcomes using a large, single, contemporary, population-based cohort. We applied a consistent approach to minimise reverse causality and residual confounding. We also investigated effect modification by key individual-level characteristics and estimated absolute effects of BMI on mortality outcomes.
Methods

Study design and setting
We did a cohort study using prospectively collected data from the UK Clinical Practice Research Datalink (CPRD) linked to national death registration data. The CPRD contains primary care records from general practitioners (GPs) covering around 9% of the UK population; linkage to death registration data, including the date and causes of death, was available for 80% of GP clinics in England. CPRD data, including the linked subset, have been shown to be broadly representative of the general population in terms of age, sex, ethnicity, and BMI. [12] [13] [14] [15] The study protocol was approved by the London School of Hygiene & Tropical Medicine Ethics Committee (14389) and the Independent Scientific Advisory Committee for MHRA Database Research (protocol number 16_174, approved Aug 24, 2016 , and provided in the appendix).
Participants, exposures, and outcomes
We included all individuals with BMI data collected at age 16 years and older and with subsequent follow-up time available; BMI data were processed as described
Research in context
Evidence before the study Two meta-analyses published in 2016 reviewed studies of associations between BMI and all-cause mortality. The first found a J-shaped association with lowest risk at a BMI of 23-24 kg/m² among never-smokers. Inclusion of smokers and people with existing but undiagnosed illnesses were identified as important potential sources of bias. The second, by the Global BMI Mortality Collaboration, was an individual patient data meta-analysis and found a similar pattern, largely consistent across four continents. In the absence of any broad systematic reviews examining the association of BMI and cause-specific mortality outcomes, we searched PubMed for articles published in the past 10 years (Jan 1, 2007, to Dec 31, 2017) and retrieved 67 studies that investigated associations between BMI (as a continuous variable or in at least three categories) and one or more cause-specific mortality outcomes. The search string was ("body mass index" OR bmi OR obes*OR overweight) AND (mortality OR death); inclusion and exclusion criteria are listed in the appendix. The 67 included studies are described in the appendix; deaths from cardiovascular disease, cancer, and respiratory disease were most often studied, whereas only a small number of studies investigated deaths from other causes-namely, diabetes, external causes, liver or digestive diseases, kidney diseases, and infectious diseases. Only six studies investigated four or more of these categories of causes. Findings for cause-specific mortality outcomes from studies based in European, North American, Australian, and trans-continental settings (probably the most comparable to our data) are summarised in the appendix. Positive or J-shaped associations were observed for most cardiovascular disease mortality outcomes; associations between BMI and cancer mortality were smaller overall but varied by cancer site; inverse or U-shaped associations were reported for respiratory deaths, and for other outcomes there was limited evidence. Analogous results from 30 studies in Asian settings are also summarised in the appendix.
Added value of this study
To the best of our knowledge, this is one of the largest single cohort studies of its kind to date that quantifies the associations between BMI and a comprehensive range of mortality outcomes at three levels of granularity, including several outcomes for which few previous data are available. We built on previous evidence by using flexible spline models to examine non-linearity in detail, and we also investigated potential effect modification. We used consistent methodology throughout to minimise confounding and reverse causality, and did extensive sensitivity analyses.
Implications of all the available evidence
Important associations exist between BMI and almost every category of mortality outcome. In contrast with some previous evidence suggesting that overweight might be protective, we found that risk began to increase above 21-25 kg/m² for most outcomes, including all-cause mortality, cardiovascular disease, and cancer. However, for mental and behavioural, neurological, and external causes, only lower BMI was associated with increased risk. We found strong evidence of effect modification by age; further work is needed to explore the drivers of this effect and thus understand whether healthy weight recommendations might need to take age into consideration.
See Online for appendix elsewhere. 12 Exposure was assigned as the earliest BMI recorded during CPRD research-standard follow-up (appendix); 14 in the absence of BMI recorded at the start of follow-up, we used the most recent historical BMI record (if available) and updated it at the date of the first BMI during follow-up.
To minimise reverse causality (disease leading to weight change), we excluded the first 5 years of followup after the BMI record. Follow-up began at whichever was the latest of: start of CPRD research-standard follow-up, the 5-year anniversary of the first BMI record, or on Jan 1, 1998 (start date for death registration data); 16 We studied all Level 1 outcomes (communicable diseases, non-communicable diseases, and injuries and external causes); all Level 2 noncommunicable disease outcomes (high-level disease groupings such as cancer and cardiovascular disease), and selected Level 3 outcomes (specific disease and injury types, such as lung cancer and heart failure) that were either common causes of death in the UK, 17 or were a priori expected to have important associations with BMI (the full list of outcomes with ICD codes is provided in the appendix).
Underweight
Statistical analysis
Cox regression models with an age timescale were fitted for all-cause mortality and for each cause-specific mortality outcome, censoring deaths from competing causes. 18 BMI was initially fitted in WHO categories, 19 then in finer BMI categories as used by the Global BMI Mortality Collaboration (to aid comparison with work based on this classification), 4 and then as a restricted cubic spline (smooth curve). Fully adjusted models were stratified by sex and adjusted for baseline age, smoking, alcohol use, diabetes, index of multiple deprivation (a measure of socioeconomic status 20 We fitted interactions to investigate effect modification by sex, current age, smoking, index of multiple deprivation quintile, and (among those with available data) ethnicity. To quantify absolute effects, we estimated the expected age of death for men and women aged 40 years by BMI category using a simplified Poisson model including BMI category, age, sex, and interactions between these variables. Age 40 years was chosen as this was the approximate median age at entry and there were few deaths at younger ages; full details of the methods are provided in the appendix. Population attributable fractions were calculated by combining hazard ratios (HRs) from the nine-category BMI model with observed deaths in each BMI category. 21 Cumulative incidences of mortality from cardiovascular disease, cancer, neurological causes, and respiratory causes were also calculated by BMI category by use of competing risks methods.
18
Sensitivity analyses
First, we varied the amount of initial follow-up time after the BMI record that was excluded between 0 years and 10 years; in the primary analysis the first 5 years were excluded to minimise reverse causality. Second, we excluded individuals with prevalent cancer or cardiovascular disease at the start of follow-up for those respective mortality outcomes, to further explore possible reverse causality; we also excluded individuals with previous chronic obstructive pulmonary disorder from the respiratory mortality analysis; dementia or Alzheimer's disease from the neurological mortality analysis; and depression, bipolar disorder, or schizophrenia from the analyses of deaths from mental and behavioural causes and from self-harm and interpersonal violence. Third, we considered alternative non-linear parametrisations of BMI-namely, very fine categories of 1 kg/m² width (18·0-18·9 kg/m², 19·0-19·9 kg/m², and so on), and a two-term fractional polynomial. 22 Fourth, we adjusted for ethnicity where such data were available. Fifth, we dropped adjustment for diabetes, then excluded patients with diabetes entirely, in case diabetes might act as an intermediary. Sixth, we dropped BMIs recorded before the start of research-standard CPRD follow-up. Seventh, we restricted the analysis to patients who had a BMI record less than 12 months after registration (more likely because of administrative reasons rather than clinically motivated). Finally, we explored the effect of 
NA* 0·87 (0·80-0·94) ··
HR=hazard ratio. ICD-10=International Classification of Diseases, 10th revision. NA=not available. *For transport-related accidents, and self-harm and interpersonal violence, there was little or no evidence against linearity (figure 2) so a single linear effect without change point was estimated. Table 2 : Estimated change points in the association between BMI and mortality among never-smokers, and associations with mortality below and above the change point, from piecewise two-line models for the 5-year post-BMI exclusion period
Figure 2: Association between BMI and Level 2 and Level 3 cause-specific mortality outcomes among never-smokers (organised by ICD-10 code)
We used a three-level hierarchical classification of causes of death as used by the Global Burden of Diseases, Injuries, and Risk Factors Study. 16 We studied all Level 2 non-communicable disease outcomes and selected Level 3 outcomes that were either common causes of death in the UK or were a priori expected to have important associations with BMI. 5-year exclusion period applied for person-time and events after a BMI record; estimates adjusted for age, deprivation, calendar year, diabetes, alcohol status (all as defined at date of BMI measure) and stratified for sex. HR=hazard ratio. ICD-10=International Classification of Diseases, 10th revision. missing BMI by restricting analyses to more recent calendar periods in which BMI completeness was higher.
Role of the funding source
The sponsor had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.
Results
Of data from 8 093 746 individuals from CPRD practices in England, 3 632 674 were included in the study after excluding data from individuals with no linked mortality data, BMI data, or BMI data outside of the plausible range (15-50 kg/m²), and from individuals followed up for less than 5 years after BMI measure (appendix). Of individuals included in the study, 1 969 648 were neversmokers. 367 512 deaths were observed (188 057 among never-smokers; Associations between BMI and mortality were J-shaped for all-cause, communicable, and non-communicable disease mortality. For injuries and external causes, a marked increase in risk was observed at low BMIs, but minimal elevation in risk at higher BMIs (figure 1). Restriction to never-smokers slightly attenuated the association at low BMIs for all these outcomes (figure 1) and also for cancer mortality (appendix). The nadir for all-cause mortality risk among never-smokers was estimated from piecewise linear models to be at a BMI of 25 kg/m² (table 2) .
Estimated associations between BMI and more specific mortality outcomes are shown from non-linear spline models (figure 2) and from linear and piecewise linear models (table 2) in never-smokers (analagous results in the full study population including smokers are provided in the appendix). For 11 of 13 Level 2 mortality outcomes, there was evidence of non-linearity, with two main patterns seen: for eight outcomes (cancer, cardiovascular, respiratory, blood/endocrine, liver cirrhosis, other digestive, musculoskeletal, and urogenital causes), we estimated the mortality risk to reach a nadir at BMIs in the range of 21-25 kg/m², with inverse associations below, and positive associations above, although the magnitude of associations varied; for three outcomes (mental and behavioural, neurological, and accidental [non-transport-related]), we found inverse associations below a BMI of 24-27 kg/m², with little evidence of association at higher BMIs. We estimated a linear inverse association between BMI and deaths from self-harm and interpersonal violence (HR 0·87 per 5 kg/m² increase; 95% CI 0·80-0·94); we found no evidence of association between BMI and deaths from transport-related accidents.
The overall pattern of association between BMI and cardiovascular death was similar for most Level 3 cardiovascular outcomes but was more muted for cerebrovascular deaths (figure 2). Broadly positive associations were observed between BMI and 12 of 15 site-specific cancer mortality outcomes, with evidence of non-linearity for oesophageal, stomach, uterus, prostate, and kidney cancers, generally reflecting a weak association at the lowest BMIs, although for oesophageal cancer there was a J-shaped association. BMI was not associated with deaths from lung cancer, brain or CNS cancer, or malignant melanoma.
Results from categorical BMI models are in the appendix.
High BMI was more strongly associated with overall and cardiovascular mortality in men than in women ( figure 3; appendix) . Most associations between BMI and mortality were attenuated at older ages ( figure 3;  appendix) . In a post-hoc analysis we estimated the nadir of all-cause mortality risk to be 23 kg/m² at age younger than 70 years, rising to 25 kg/m² at age 70 years and older. We found no evidence of effect modification by deprivation (appendix). Investigation of effect modification by ethnicity was limited by low power and we only considered all-cause mortality; despite some difference in the observed patterns by ethnicity, particularly at low BMI, there was insufficient evidence to rule out chance variation (appendix). The expected age of death for a 40-year-old neversmoker with healthy weight was 82·2 years for men and 84·3 years for women (table 3) . Underweight, overweight, and obesity were all associated with reductions in these life expectancies: obesity overall was associated with shortening of life expectancy by 4·2 years in men and by 3·5 years in women; class 3 obesity was associated with shortening of life expectancy by 9·1 years in men and by 7·7 years in women.
Assuming causality, we estimated that 4·3% of all deaths might be attributable to obesity, and 5·5% to overweight including obesity (appendix). Cumulative incidences of cause-specific mortality outcomes by BMI are shown in the appendix.
Exclusion of more initial follow-up time attenuated inverse associations at low BMI for most outcomes; exclusion of prevalent disease gave similar results to exclusion of early person-time (appendix). Other sensitivity analyses made little difference to estimated associations between BMI and mortality (appendix).
Discussion
We observed a J-shaped association between BMI and allcause mortality, with lowest mortality at 25 kg/m². BMI was associated with mortality risk from every main category of cause except for transport-related accidents. There were three broad patterns of association: for cancer, cardiovascular, respiratory, blood and endocrine, digestive, musculoskeletal, and urogenital causes of death, we found J-shaped associations with nadirs at 21-25 kg/m², and varying magnitudes of association; for mental and behavioural, neurological, and accidental (non-transport-related) causes, BMI was inversely associated with mortality up to 24-27 kg/m² with little association above this point; and BMI was inversely and linearly associated with deaths from self-harm and interpersonal violence. Associations between high BMI and several mortality outcomes attenuated with age and were stronger in men than in women. Obesity was associated with a 4·2-year reduction in remaining life expectancy for a male 40-year-old never-smoker and a 3·5-year reduction for a female 40-year-old never smoker, when compared with individuals of healthy weight, with longest reductions in life expectancy estimated for the most severely obese (class 3) individuals; underweight was associated with a reduction in life expectancy of more than 4 years.
The J-shaped association we observed between BMI and all-cause mortality was consistent with results from some major studies, 2,4 but others have estimated a reduced risk among overweight individuals compared with those of healthy weight. 6 Reverse causality and residual confounding (in particular by smoking) might partly explain the discrepant results between studies; associations between overweight and mortality are attenuated in studies with short follow-up, or in studies that include smokers. 2 We also observed clear heterogeneity in the associations between BMI and different causes of death, and strong interactions with age, meaning that the association of all-cause mortality with BMI in any individual study will be affected by the age and cause-of-death distributions in the source population.
In the absence of broad evidence summarising causespecific mortality outcomes, we did a systematic literature review and identified 67 relevant studies from 2007 to 2017 for comparison (appendix). Most studies either excluded an initial follow-up period of 1-10 years (n=20) or excluded people with previous disease (n=11), or excluded both (n=13). Most studies of overall cardiovascular mortality from similar settings found approximately J-shaped associations, consistent with our results (appendix); only a few examined more specific cardiovascular mortality outcomes. J-shaped associations were similarly seen for deaths from coronary heart disease and heart failure, and, in some studies, for cerebrovascular deaths; 4, 5 however, more modest associations between BMI and cerebrovascular death were also observed, as in the present analysis. 24 Ischaemic and haemorrhagic stroke were rarely distinguished, despite their potentially different associations with BMI. 5 Most previous evidence about cancer mortality has focused on any cancer type or on breast, colorectal, lung, and prostate cancers, with less common cancers infrequently studied (appendix). Studies into prostate cancer mortality generally imposed linearity or used few BMI categories; our results suggest important non-linearity in the association, with a levelling off or reduction in risk at the highest BMIs. Various studies agreed with our finding of no association between BMI and lung cancer mortality, whereas others found both strong positive and negative associations, possibly reflecting the complications of adequately accounting for smoking. Few studies looked at mortality outcomes other than those from cardiovascular disease and cancer (appendix). The raised risks of many outcomes at low BMI, coupled with the fact that mental health conditions showed the strongest inverse associations with low BMI, might indicate pervasive effects of mental health problems on a range of outcomes, through pathways that could include poorer self-care and less access to or use of health-care services, or both. The persistence of inverse associations between BMI and deaths from self-harm and interpersonal violence even in sensitivity analyses in which follow-up was started up to 10 years after BMI recording, or when individuals with previously recorded mental illness were excluded, argues against reverse causality. However, it remains possible that depression and related diseases leading to appetite suppression even over a long time period or without a formal diagnosis could partly explain this finding. Imposing a longer period between BMI recording and study entry tended to attenuate associations between low BMI and outcomes; this might have been observed because a side-effect of this approach is to reduce the amount of person-time included at young ages, and we separately found the strongest associations between low BMI and mortality to be in younger people. The analyses stratified by age also suggested that mortality was minimised in older individuals at higher BMI, perhaps indicating increased importance of nutritional reserves in older age. This finding might suggest that healthy weight recommendations need to account for age, but further work is needed to establish whether increased weight is actually beneficial for older individuals: there is increased risk of reverse causation in older people because of the increased prevalence of most diseases, and BMI might be compromised as a measure of adiposity in the oldest individuals because of complications from loss of muscle mass. 25 In this study, we systematically analysed outcomes at different levels of granularity, used consistent methodology to deal with confounding and reverse causality, and did a wide range of sensitivity analyses. A particular strength was that the size of the study allowed us to retain power while restricting analyses to never-smokers and thus minimising confounding by smoking. BMI data in the CPRD have good validity and representativeness. 12 In preliminary analyses, we validated linked mortality data by comparing these with data recorded directly in primary care records; dates of death agreed to within 1 month in 97% of cases.
25% of individuals who were otherwise eligible were excluded because they had no BMI records available. This complete case analysis approach is valid provided that absence of data is conditionally independent of the outcome under study; 26 we considered this approach more appropriate than multiple imputation, because underweight and overweight individuals would be more likely to have their BMI recorded in primary care, contradicting the required missing at random assumption. 27 Several sensitivity analyses suggested that missing BMI data had little effect on our estimates: there was little change in results when analyses were restricted to more recent calendar years, despite BMI data complete ness increasing from 66% to 80% in 2000-15. There might have been inaccuracies in cause of death recording. Different physicians could differently interpret the underlying cause of death, and certification of deaths in hospital could be completed by one of several doctors in a team, increasing the risk of classification errors. 28 Some causes of death might be particularly prone to misclassification: we noted a relatively large number of deaths attributed to pneumonia, which might have been secondary to other morbidities. Clear national guidance about certification should have helped reduce errors. 28 If any mis classification was unrelated to BMI, the expected impact on our analysis would be loss of power. We might also have missed deaths that were not registered in the UK because of emigration, but these are likely to represent a small proportion of deaths. We had no data about diet, physical activity, or cardiorespiratory fitness, with which we could have further explored causal pathways and confounding, 29, 30 and we had no data about measures of adiposity other than BMI.
In conclusion, BMI had a J-shaped association with overall mortality, and BMI outside the healthy range was associated with up to several years of lost lifespan, with most of the absolute mortality burden driven by obesity (BMI ≥30 kg/m²). However, the overall association between BMI and mortality was driven by varying associations with individual cause-specific mortality outcomes, including predominantly inverse associations for mental and behavioural, neurological, and external causes. Associations between BMI and mortality varied by age; an improved understanding of the reasons for this interaction could help inform age-specific public health recommendations.
